Home
Smart & Biggar
Chen Li
Chen Li
Smart & Biggar
Celebrating World IP Day 2024
06 May 2024 | Canada
Generic Submissions Under Review List Will Identify Generic Filers
02 Apr 2024 | Canada
Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex
03 Mar 2023 | Canada
Federal Court Of Appeal Restores Minister Of Health's Decision To Grant RUZURGI NOC Despite FIRDAPSE Data Protection
26 Jan 2023 | Canada
Federal Court Of Appeal Upholds Obviousness Finding Re: Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent
22 Nov 2022 | Canada
Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay
27 Sep 2022 | Canada
Federal Court Finds Janssen's Macitentan Combination Therapy Patent Valid
28 Jun 2022 | Canada
Competition Bureau Resolves Misleading Performance Claims Case
31 May 2022 | Canada
Federal Court Sets Aside Decision By The Minister Of Health To Issue RUZURGI NOC For The Second Time
31 Mar 2022 | Canada
PMPRB Releases Report On Expensive Drugs For Rare Diseases
22 Feb 2022 | Canada
Regulatory Amendments Provide Permanent Measures To Address Therapeutic Product Shortages
02 Oct 2021 | Canada
Federal Court Of Appeal Confirms Janssen's SPRAVATO Not Eligible For Data Protection
02 Aug 2021 | Canada
Federal Court Of Appeal Upholds Decision Allowing Taro To Plead Validity Attacks Beyond Notice Of Allegation
02 Jul 2021 | Canada
Transition Measures Released For Interim Order For COVID-19 Drugs
04 May 2021 | Canada
Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent Found Invalid
02 Feb 2021 | Canada
First Year Of Project Orbis Leads To 38 Approvals Of Cancer Therapies, Including 8 By Health Canada
02 Feb 2021 | Canada
Supreme Court Denies Leave In Perindopril Accounting Of Profits Decision
04 Nov 2020 | Canada
Supreme Court Of Canada Leave Applications - May 2020
10 Jun 2020 | Canada
From Regulatory Flexibility To Reimbursement Changes, How Canadian Regulators And Payers Are Managing The COVID-19 Crisis
13 May 2020 | Canada
Federal Court Of Appeal Dismisses Pfizer's Appeal Of Interlocutory Decision In Pregabalin Section 8 Case: Infringement Not A Viable Defence Where Patentee Did Not Sue In Real World
21 Apr 2020 | Canada
< 1 2 >
Contact Details
Toronto
Email Website
Toronto
Canada

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.